USPTO 2015–2025 USPTO PatentsView US Corporation

C.r. Bard, Inc.

USPTO PatentsView assignee record - 808 granted patents across 58 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

808
Total patents granted
58
CPC technology areas
16.8
Avg claims per patent
-4%
5-year filing velocity

The verdict

C.r. holds 808 US patents across 58 technology areas, rank #554 of 50,000 tracked assignees.

#554
of 50,000 US assignees by volume
Top 2%
by Innovation Score (62.9/100)
16.8
avg claims per patent
-4%
filing velocity, last 5 yrs

Portfolio overview

C.r. Bard, Inc. has been granted 808 US utility patents between 2015 and 2025, placing C.r. Bard, Inc. at rank #554 across all assignees tracked by PlainPatent. This portfolio spans 58 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, C.r. Bard, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, C.r. sits between Saint-gobain Glass France (820 patents, rank #550) and KING Faisal University (803 patents, rank #558) - the closest US assignees by grant volume. The composite Innovation Score of 62.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 396 grants, compared with 412 in the 2015–2019 window, a -4% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. C.r. Bard, Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 58 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark C.r. Bard, Inc. against peers pursuing similar technology classes.

Who files at Cr's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows C.r. holds 808 patents at rank #554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cr

By rank, the assignees closest to #554 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Cr's primary technology class.

C.r.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 43
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
C.r. Bard, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 80 9.9%
2016 73 9.0%
2017 83 10.3%
2018 71 8.8%
2019 105 13.0%
2020 86 10.6%
2021 79 9.8%
2022 54 6.7%
2023 68 8.4%
2024 66 8.2%
2025 43 5.3%

Which technologies does C.r. Bard, Inc. patent most?

Top 15 of 58 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#554

Across all tracked assignees

Innovation Score

62.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does C.r. Bard, Inc. hold?
C.r. Bard, Inc. holds 808 US granted patents filed between 2015 and 2025, spanning 58 technology areas.
What is C.r. Bard, Inc.'s Innovation Score?
C.r. Bard, Inc. has an Innovation Score of 62.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does C.r. Bard, Inc. focus on?
C.r. Bard, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 383 patents. The company has filed patents in 58 CPC subclasses total.
Is C.r. Bard, Inc.'s patent filing rate increasing or decreasing?
C.r. Bard, Inc.'s recent filing velocity is -4% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for C.r. Bard, Inc.'s patents?
C.r. Bard, Inc.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the C.r. Bard, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

C.r.'s 808 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - C.r. ranks #554 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.